Factor 8 Gene Roctavian denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for factor 8 gene roctavian are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Roctavian (valoctocogene roxaparvovec) — Medical Necessity

Roctavian is a one-time AAV gene therapy FDA-approved for adults with severe hemophilia A who currently use Factor VIII prophylaxis. Cigna's medical-necessity denial means its reviewer determined that the clinical documentation submitted does not sufficiently establish that Roctavian — rather than continued standard Factor VIII replacement therapy — is medically required for this patient. Medical-necessity denials for gene therapy are common at initial PA and are frequently overturned on appeal when the clinical picture is fully documented.

## Why This Denial Is Appealable

Cigna's coverage policy for Roctavian will list specific clinical criteria — typically relating to diagnosis severity, current treatment burden, absence of certain contraindications, and HTC involvement. A medical-necessity denial almost always means the submitted documentation did not address every criterion explicitly. An appeal that maps each policy criterion to a specific chart fact, supported by a detailed prescriber letter from an experienced hematologist, resolves the majority of these denials. The appeal is not about relitigating whether gene therapy is appropriate in general — it is about demonstrating that this patient, specifically, meets Cigna's stated criteria.

## Federal Appeal Framework

• Internal appeal: File with Cigna within 180 days. For a treatment with this level of clinical significance, also request a clinical peer-to-peer review between your hematologist and Cigna's medical director before or during the appeal.
• External review (ACA §2719): After final internal denial, you have approximately four months to request independent external review by an IRO not affiliated with Cigna. External reviewers assess whether the denial met accepted clinical standards.
• ERISA §503: For employer-sponsored plans, you are entitled to the specific medical criteria and clinical guidelines applied, the name and specialty of the reviewing clinician, and the opportunity to submit a rebuttal.
• Expedited review: Available if a delay would seriously jeopardize health or ability to undergo the procedure (e.g., treatment window or surgical scheduling constraints).

## Documentation to Gather

1. Confirmed severe hemophilia A diagnosis — lab documentation of Factor VIII activity level consistent with severe disease, from your hematologist's records. 2. Prophylaxis history — complete records of current and prior Factor VIII prophylaxis regimens: products used, frequency, duration, and clinical outcomes. 3. Annualized bleed rate (ABR) — documentation of bleeding events on current prophylaxis, including joint bleeds, spontaneous bleeds, and any hospitalizations. 4. Joint assessment — orthopedic or MRI documentation of hemophilic arthropathy or joint status, if applicable. 5. HTC evaluation and candidacy letter — a letter from the hemophilia treatment center confirming the patient has been evaluated and is a candidate for gene therapy, addressing the criteria in Cigna's policy. 6. Prescriber medical-necessity letter — a detailed, criterion-by-criterion letter from the treating hematologist explaining why Roctavian is medically necessary for this patient. 7. Cigna's current medical/coverage policy — download the specific policy and use it as the template for the appeal.

## Criteria-Mapping Structure

Your appeal letter must address each of Cigna's medical-necessity criteria individually: - Column A: Copy each criterion verbatim from Cigna's published coverage policy. - Column B: The specific chart fact, lab result, clinical note, or letter that satisfies that criterion, with the document name and date.

Do not assume Cigna's reviewer will connect the dots — make every match explicit. Attach all supporting documents as numbered exhibits referenced in the letter body.